PRZOOM - /newswire/ - Monrovia, CA, United States, 2008/12/31 - Charles Peterfy, CSO at Synarc will give the featured presentation at GTCbio’s 4th annual Imaging in Preclinical & Clinical Drug Development Conference on March 16-17, 2009 in San Francisco, CA.

Dr. Charles Peterfy, Chief Scientific Officer at Synarc in San Francisco, CA will give the featured address entitled “Successful Multi-Site MRI in Rheumatoid Arthritis Clinical Trials: Overcoming Single-Site Mindedness.” at GTCbio’s 4th annual Imaging in Preclinical & Clinical Drug Development Conference on March 16-17, 2009 in San Francisco, CA.

Dr. Peterfy’s presentation will examine the unique challenges to successful multi-site magnetic resonance imaging (MRI) in clinical trials of Rheumatoid Arthritis (RA). He will specify the critical image-quality drivers of accurate readings, which elements of the MRI protocol are most important to these image attributes, and techniques that can ensure good images.

Dr. Peterfy is co-founder and Chief Scientific Officer of Synarc, an international organization providing centralized medical imaging and molecular marker services and clinical-research facilities to the pharmaceutical, biotechnology and medical devices industries. He is a board-certified radiologist with 20 years experience in clinical radiology and fellowship training in musculoskeletal imaging from the University of California San Francisco.

4th Annual Imaging in Clinical & Pre-clinical Drug Development Conference will give attendees a comprehensive look at the latest developments in preclinical and clinical imaging including the advancements in PET Probe and In Vivo MRI; it will help attendees alleviate the biggest issues such as cost and the understanding of FDA regulations.

Agency / Source: GTCbio - Biopharmaceutical Conference

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

Distribution / Indexing: [+]